linezolid accord
accord healthcare b.v. - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
linezolid krka
krka, d.d., novo mesto - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
linezolid krka
krka, d.d., novo mesto - linezolidas - plėvele dengtos tabletės - 600 mg - linezolid
linezolid norameda
norameda, uab - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
linezolid sandoz
sandoz d.d. - linezolidas - plėvele dengtos tabletės - 600 mg - linezolid
vancomycin kabi
fresenius kabi polska sp.z.o.o. - vankomicino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 1000 mg; 500 mg - vancomycin
vancomycin mylan
mylan s.a.s. - vankomicinas - milteliai infuzinio tirpalo koncentratui - 1000 mg; 500 mg - vancomycin
vancosan
mip pharma gmbh - vankomicinas - milteliai infuziniam tirpalui - 500 mg; 1000 mg - vancomycin
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - kiti antineoplastiniai agentai - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
floxelan
medochemie ltd. - moksifloksacinas - plėvele dengtos tabletės - 400 mg - moxifloxacin